These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19619564)

  • 1. The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist.
    Zhang HX; Lyons-Warren A; Thio LL
    Neuropharmacology; 2009; 57(5-6):551-5. PubMed ID: 19619564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine.
    Zhang HX; Hyrc K; Thio LL
    J Physiol; 2009 Jul; 587(Pt 13):3207-20. PubMed ID: 19433577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
    Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
    J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
    Komatsu H; Furuya Y; Sawada K; Asada T
    Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of the glycine transporter 1 on bullfrog retinal cones.
    Zhang XJ; Ge LH; Liu J; Yang XL
    Neuroreport; 2008 Nov; 19(17):1667-71. PubMed ID: 18841092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
    Chen L; Muhlhauser M; Yang CR
    J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GlyT1 Inhibitor NFPS Exerts Neuroprotection via GlyR Alpha1 Subunit in the Rat Model of Transient Focal Cerebral Ischaemia and Reperfusion.
    Huang B; Xie Q; Lu X; Qian T; Li S; Zhu R; Yu W; Chen G; Chen Z; Xu X; Wang T; Li L
    Cell Physiol Biochem; 2016; 38(5):1952-62. PubMed ID: 27161043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.
    Huang H; Barakat L; Wang D; Bordey A
    J Physiol; 2004 Nov; 560(Pt 3):721-36. PubMed ID: 15331688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site.
    Debrouse L; Hurd B; Kiselycznyk C; Plitt A; Todaro A; Mishina M; Grant SG; Camp M; Gunduz-Cinar O; Holmes A
    Alcohol Clin Exp Res; 2013 Feb; 37(2):223-33. PubMed ID: 22934986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport.
    Aubrey KR; Vandenberg RJ
    Br J Pharmacol; 2001 Dec; 134(7):1429-36. PubMed ID: 11724748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury.
    Kodama D; Ono H; Tanabe M
    Pain; 2011 Apr; 152(4):809-817. PubMed ID: 21295405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.
    Tanabe M; Nakano T; Honda M; Ono H
    J Pharmacol Sci; 2009 Mar; 109(3):444-8. PubMed ID: 19270429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D; Wildförster V; Thomsen C
    Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices.
    Chattipakorn SC; McMahon LL
    J Neurophysiol; 2002 Mar; 87(3):1515-25. PubMed ID: 11877523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.